Literature DB >> 19304694

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.

Muriel Webb1, Hanny Yeshua, Shira Zelber-Sagi, Erwin Santo, Eli Brazowski, Zamir Halpern, Ran Oren.   

Abstract

OBJECTIVE: Quantification of liver steatosis is clinically relevant in various liver diseases but cannot be done by conventional sonography, which only provides a qualitative assessment with significant observer variability. The aim of this study was to assess sonography as an objective tool for the quantification of liver steatosis.
MATERIALS AND METHODS: Files of 111 patients with chronic liver disease who were referred for sonographically guided liver biopsy were collected. A hepatorenal sonographic index was calculated on the basis of the ratio between the echogenicity of the liver and that of the right kidney cortex using histogram echo intensity. Liver steatosis was graded by histology.
RESULTS: A significant correlation was found between histologic steatosis and the hepatorenal sonographic index (r = 0.82, p < 0.001). The validity of the hepatorenal sonographic index for the diagnosis of fatty liver was compared with liver biopsies with a steatosis level > 5%. The area under the receiver operating characteristic curve was 99.2% (95% CI, 98-100%). The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis > 5% was 1.49, with sensitivity of 100% and specificity of 91%. The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis >/= 25% was 1.86, with sensitivity of 90% and specificity of 90%. The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis >/= 60% was 2.23, with sensitivity of 90% and specificity of 93%.
CONCLUSION: The hepatorenal sonographic index is a sensitive noninvasive method for steatosis quantification. It can diagnose small amounts of liver fat that would be missed by conventional sonography. It is reproducible and operator independent and can serve as an efficient tool to follow patients with steatosis and evaluate the efficacy of new treatment techniques.

Entities:  

Mesh:

Year:  2009        PMID: 19304694     DOI: 10.2214/AJR.07.4016

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  71 in total

1.  High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

Authors:  Matteo Nicola Dario Di Minno; Antonella Tufano; Anna Rusolillo; Giovanni Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.

Authors:  Shira Zelber-Sagi; Assaf Buch; Hanny Yeshua; Nahum Vaisman; Muriel Webb; Gil Harari; Ofer Kis; Naomi Fliss-Isakov; Elena Izkhakov; Zamir Halpern; Erwin Santo; Ran Oren; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

4.  Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy.

Authors:  Shiri Sherf-Dagan; Shira Zelber-Sagi; Assaf Buch; Nir Bar; Muriel Webb; Nasser Sakran; Asnat Raziel; David Goitein; Andrei Keidar; Oren Shibolet
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

5.  Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Authors:  Shira Zelber-Sagi; Muriel Webb; Nimer Assy; Laurie Blendis; Hanny Yeshua; Moshe Leshno; Vlad Ratziu; Zamir Halpern; Ran Oren; Erwin Santo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 6.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

7.  Hepatic steatosis in overweight/obese females: new screening method for those at risk.

Authors:  Giovanni Tarantino; Genoveffa Pizza; Annamaria Colao; Fabrizio Pasanisi; Paolo Conca; Patrizia Colicchio; Carmine Finelli; Franco Contaldo; Carolina Di Somma; Silvia Savastano
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

8.  Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes.

Authors:  Yongqiang Li; Shuangshuang Zhu; Bin Li; Xiaofei Shao; Xinyu Liu; Aiqun Liu; Bifang Wu; Ying Zhang; Honglei Wang; Xiaohong Wang; Kangping Deng; Qin Liu; Min Huang; Hongmei Liu; Harry Holthöfer; Hequn Zou
Journal:  Int Urol Nephrol       Date:  2014-08-07       Impact factor: 2.370

9.  Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.

Authors:  Goutam Ghoshal; Roberto J Lavarello; Jeremy P Kemmerer; Rita J Miller; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2012-10-11       Impact factor: 2.998

10.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.